Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Standard Care for Fungal Prevention in Liver Transplant
NCT01058174Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of micafungin in invasive fungal disease (IFD), sponsored by Astellas Pharma. Started Dec 2009; status: completed.
02
Drugs
micafungin
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT01058174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01058174.